The bone marrow during recovery from drug induced agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced* / Q000473:pathology; D000700:Analgesics / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001381:Azepines / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D003092:Colitis / Q000188:drug therapy; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008620:Meprobamate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009504:Neutrophils; D010630:Phenindione / Q000009:adverse effects* / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013997:Time Factors
D000700:Analgesics; D001381:Azepines; D010630:Phenindione; D008620:Meprobamate; D001241:Aspirin